X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

期刊標題檢索 J CARDIOVASC PH 最新評論: How long does the first instance trial take? (2024-09-19)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF CARDIOVASCULAR PHARMACOLOGY]您好,您是該頁面的第 44811 位訪客。

期刊簡介
期刊名稱JOURNAL OF CARDIOVASCULAR PHARMACOLOGY JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
LetPub Score
6.2
50 ratings
Rate

Reputation
7.6

Influence
5.0

Speed
7.0

期刊簡稱J CARDIOVASC PHARM
ISSN0160-2446
E-ISSN1533-4023
h-index91
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.100.6100.504
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Cardiology and Cardiovascular Medicine
Q2114 / 387
Category: Medicine
Subcategory: Pharmacology
Q2150 / 313

自引率 (2023-2024)3.80%自引率趨勢
掲載範囲
Journal of Cardiovascular Pharmacology is a peer reviewed, multidisciplinary journal that publishes original articles and pertinent review articles on basic and clinical aspects of cardiovascular pharmacology. The Journal encourages submission in all aspects of cardiovascular pharmacology/medicine including, but not limited to: stroke, kidney disease, lipid disorders, diabetes, systemic and pulmonary hypertension, cancer angiogenesis, neural and hormonal control of the circulation, sepsis, neurodegenerative diseases with a vascular component, cardiac and vascular remodeling, heart failure, angina, anticoagulants/antiplatelet agents, drugs/agents that affect vascular smooth muscle, and arrhythmias.

Appropriate subjects include new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects, application of drugs to gain novel insights into physiology or pathological conditions, clinical results with new and established agents, and novel methods. The focus is on pharmacology in its broadest applications, incorporating not only traditional approaches, but new approaches to the development of pharmacological agents and the prevention and treatment of cardiovascular diseases. Please note that JCVP does not publish work based on biological extracts of mixed and uncertain chemical composition or unknown concentration.
官方網站http://journals.lww.com/cardiovascularpharm/pages/default.aspx
在線稿件提交https://www.editorialmanager.com/JCVP
開放訪問No
出版商Lippincott Williams and Wilkins Ltd.
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1979
每年文章數93每年文章數趨勢
黃金OA百分比14.35%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CARDIAC & CARDIOVASCULAR SYSTEMSSCIEQ284/220
PHARMACOLOGY & PHARMACYSCIEQ2173/354
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0160-2446%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: About 97.5%
參考鏈接
相關期刊 【JOURNAL OF CARDIOVASCULAR PHARMACOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews CardiologyH-index: 105

    CiteScore: 53.10
    EUROPEAN HEART JOURNALH-index: 265

    CiteScore: 39.30
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGYH-index: 394

    CiteScore: 42.70
    EUROPEAN JOURNAL OF HEART FAILUREH-index: 119

    CiteScore: 27.30
    CARDIOVASCULAR RESEARCHH-index: 202

    CiteScore: 21.50
    Circulation-Arrhythmia and ElectrophysiologyH-index: 87

    CiteScore: 13.70
    EUROPACEH-index: 92

    CiteScore: 10.30
    Circulation-Heart FailureH-index: 88

    CiteScore: 12.90
    BASIC RESEARCH IN CARDIOLOGYH-index: 86

    CiteScore: 16.30
    TRENDS IN CARDIOVASCULAR MEDICINEH-index: 92

    CiteScore: 18.70
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Cardiology111404
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY106018
    CARDIOVASCULAR RESEARCH104545
    EUROPEAN HEART JOURNAL65510
    HEART57505
    CARDIOLOGY52136
    BASIC RESEARCH IN CARDIOLOGY48319
    AMERICAN JOURNAL OF CARDIOLOGY46700
    CLINICAL CARDIOLOGY39953
    CIRCULATION JOURNAL39490
  •  

    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)
  [JOURNAL OF CARDIOVASCULAR PHARMACOLOGY] 的評論撰寫評論
作者: 大夫徐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-19 23:53:48 評論於
How long does the first instance trial take?
(0) 讚! | 大夫徐

作者: 扑哧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-14 09:03:03 評論於
Please submit on Aug 9 24, first review by RRC on Sep 7, DIP on Sep 7 until now is still DIP, it has been a week. Give me a major revision.
(0) 讚! | 扑哧

作者: 璃月晨希


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-24 10:43:31 評論於
Could the original poster please send the full text to the author outside of OA?
(0) 讚! | 璃月晨希

作者: 南川南琴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-27 14:21:57 評論於
2023.5.26 under review
Date updated
(0) 讚! | 南川南琴

作者: 南川南琴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-23 19:54:40 評論於
2023.5.23 under review
(0) 讚! | 南川南琴

作者: 南川南琴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-20 08:56:46 評論於
2023.5.19 (Thursday) Change format
2023.5.20 Change format
(0) 讚! | 南川南琴

作者: 南川南琴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-16 10:38:17 評論於
Revised on May 10, 2023, there has been no response so far, still submitted
(0) 讚! | 南川南琴

作者: 南川南琴


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-29 18:13:38 評論於
23.3.29 Major revision for supplementing animal experiments
(0) 讚! | 南川南琴

作者: 乌龙戊子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-28 16:40:58 評論於
Decision in process
(0) 讚! | 乌龙戊子

作者: 乌龙戊子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-28 12:11:23 評論於
Required reviews completed
(0) 讚! | 乌龙戊子

作者: 小培聪吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-13 12:22:52 評論於
I have been like this for half a month. How are the subsequent results?
(0) 讚! | 小培聪吖

作者: 乌龙戊子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-10 21:51:31 評論於
Please revise the format and resubmit for review in four days after one week
(0) 讚! | 乌龙戊子

作者: 乌龙戊子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-21 13:15:07 評論於
Research Focus: Pharmacology; Cardiovascular Drugs; Sharing Experience in Cardiovascular Pharmacology: Submitted on 2/26/2023 and no news yet, no editor or manuscript number, has anyone encountered this before?
(0) 讚! | 乌龙戊子

作者: 矢泽彭泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-21 17:35:24 評論於
About 4-5 months old
(0) 讚! | 矢泽彭泽

作者: 南风修然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-07 18:51:24 評論於
I choose non-OA and don't ask for a penny
(0) 讚! | 南风修然

作者: 南风修然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-07 08:57:55 評論於
Non-OA selected, received the email for early online publishing about 1 week after acceptance. The title and abstract were available on PubMed and Web of Science within two days, but it took a month and a half for the proof
(0) 讚! | 南风修然

作者: 深渊喜悦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-21 19:32:16 評論於
May I ask if you have chosen OA or non-OA? If it is non-OA, how long does it usually take to find it in PubMed or Web of Science? Is it mentioned in the acceptance letter? Thank you!
(0) 讚! | 深渊喜悦

作者: 芦雪可爱吗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-20 19:14:13 評論於
Do you require a review fee and page charge? Thank you
(0) 讚! | 芦雪可爱吗

作者: 蒙德昭阳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-08 13:42:20 評論於
What's your status?
(0) 讚! | 蒙德昭阳

作者: 南风修然


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-26 12:16:20 評論於
Review speed: 1.0 | Submission success rate: 75.0
Focused research direction: cardiovascular
Experience: The journal reviewers are very professional, the review speed is fast, and the editors are very responsible. It takes 6-8 weeks to receive proof after being informed by email, which is a bit long. 
Nov 08, 2021 Submitted to Journal
Nov 09, 2021 Reviewer invited
Nov 24, 2021 Under Review
Dec 08, 2021 First decision (Accept with minor revision)
Jan 20, 2022 Revision Submit to Journal
Jan 21, 2022 Under Review
Feb11, 2022 Decision in process
Feb15, 2022 Decision (Accept with minor revision)
Feb17, 2022 Revision Submit to Journal
Feb 22, 2022 Required Reviews Completed
Feb 23, 2022 Decision in process
Mar 02, 2022 Accept
(0) 讚! | 南风修然

作者: 空明昆鹏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-18 16:24:47 評論於
What result did you get? I also saw this status shortly after submitting
(0) 讚! | 空明昆鹏

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 15:00:13 評論於
According to the format required by the respective magazines. If there is no fixed format, you can choose the appropriate format based on the type of article. Regardless of the format, structuring the abstract makes the data information more clear and understandable
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 12:34:20 評論於
An abstract is a summary of the content of a paper, mainly outlining the purpose of the paper, the methods used, the results obtained, and their significance
(0) 讚! | 维尔娜菲茨杰拉德

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 20:23:54 評論於
How to choose between structured and full abstracts?
(0) 讚! | 龙鳞孝礼

作者: 修然小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 16:41:00 評論於
How to write an abstract?
(0) 讚! | 修然小公主

首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)

開始撰寫 [JOURNAL OF CARDIOVASCULAR PHARMACOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*